Top Core and Group Health Stories
The 'dark money' behind the latest pro-pharma advocates
By Marlene SatterA new advocacy group is outspokenly defending high drug prices and criticizing advocates for lower drug prices. Who are they?
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
A new advocacy group is outspokenly defending high drug prices and criticizing advocates for lower drug prices. Who are they?